Web1 May 2024 · VALIDATION AND PERFORMANCE OF POINT-OF-CARE RAPID CYP2C19 GENOTYPING IN THE TAILOR-PCI MULTICENTER INTERNATIONAL RANDOMIZED CLINICAL TRIAL Request PDF VALIDATION AND PERFORMANCE OF... WebThe TAILOR-PCI Clinical Trail Results March 28th from 9:40 am - 9:52 am on the Hot Topics Channel . Study ... TAILOR F . Primary EndPoint Post-Hoc Analysis — Conventional …
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection …
Web28 Mar 2024 · The primary endpoint of TAILOR-PCI—the largest cardiology trial to test the effectiveness of using genetic testing to guide treatment choice—was to demonstrate a 50% reduction at one year in the combined rate of death, heart attack, stroke, a blood clot in a stent (stent thrombosis) or a recurrent heart attack-like presentation. Web21 Oct 2024 · The TAILOR-PCI trial (Tailored Antiplatelet Initiation to Lessen Outcomes Due to Decreased Clopidogrel Response after Percutaneous Coronary Intervention) was … gold and silver placemats
Antiplatelet therapy after percutaneous coronary intervention
Web5 Dec 2012 · TAILOR-PCI is a multi-site, open label, prospective, randomized trial testing the hypothesis that after percutaneous coronary intervention (PCI), using a genotyping … Web30 Mar 2024 · The TAILOR-PCI trial was designed to fill this knowledge gap. The trial enrolled 5,302 patients who had been treated for an arterial blockage with one or more … Web28 Mar 2024 · TAILOR PCI, an international clinical trial that used genetic testing to guide which antiplatelet medication was given to patients following percutaneous coronary … gold and silver place in ballston spa ny